Matches in SemOpenAlex for { <https://semopenalex.org/work/W8635114> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W8635114 abstract "According to CuraScript’s 2008 Specialty Drug Trend Report, based on research provided by its parent company Express Scripts, a pattern of smaller per-member, per-year pharmacy cost increases began in 2003 and reached a record low rate of 3 percent in 2008. This trend was attributed to cost per prescription, utilization, and the introduction of new drugs. Specialty drug trends may reverse this pattern, however, as in 2008, the top three classes of specialty pharmaceuticals — those treating inflammatory conditions, multiple sclerosis, and cancer — exceeded all remaining therapy classes in PMPY spending and accounted for almost 64 percent of total specialty spend.PMPY costs for 6 of the top 8 specialty therapy classes increased by double digits. Pulmonary hypertension drugs led the way with a 59 percent PMPY spending increase.“The increase in PMPY costs for pulmonary hypertension is actually a good thing from a health professional perspective. It means that physicians are now diagnosing the disease sooner and prescribing proper drugs to treat it, which is something we didn’t see 15 to 20 years ago,” says Matt Totterdale, vice president, specialty pharmacy for Express Scripts. “The mean survival rate for this condition has gone from 5 to 8.5 years, and we’re leveraging traditional pharmacy benefit management tools ... to keep drug costs down.”Cancer drugs also saw a significant increase in PMPY costs, but less so when billed under the pharmacy benefit rather than under the medical benefit. The implication is that careful management of medical benefit billing could lead to significant savings in specialty spending.“In the case of inflammatory conditions, for example, which account for the highest percentage of spending, better management of the condition has helped to keep costs down,” says Totterdale. “With new specialty products in the pipeline, costs are guaranteed to go up, but so will patients’ quality of life.”" @default.
- W8635114 created "2016-06-24" @default.
- W8635114 creator A5034470758 @default.
- W8635114 date "2009-10-01" @default.
- W8635114 modified "2023-09-23" @default.
- W8635114 title "Can Higher PMPY Costs Be a Good Thing?" @default.
- W8635114 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2799100" @default.
- W8635114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22478790" @default.
- W8635114 hasPublicationYear "2009" @default.
- W8635114 type Work @default.
- W8635114 sameAs 8635114 @default.
- W8635114 citedByCount "0" @default.
- W8635114 crossrefType "journal-article" @default.
- W8635114 hasAuthorship W8635114A5034470758 @default.
- W8635114 hasConcept C104863432 @default.
- W8635114 hasConcept C142724271 @default.
- W8635114 hasConcept C160735492 @default.
- W8635114 hasConcept C162324750 @default.
- W8635114 hasConcept C20387591 @default.
- W8635114 hasConcept C204787440 @default.
- W8635114 hasConcept C2426938 @default.
- W8635114 hasConcept C2780062483 @default.
- W8635114 hasConcept C50522688 @default.
- W8635114 hasConcept C512399662 @default.
- W8635114 hasConcept C71924100 @default.
- W8635114 hasConcept C98274493 @default.
- W8635114 hasConceptScore W8635114C104863432 @default.
- W8635114 hasConceptScore W8635114C142724271 @default.
- W8635114 hasConceptScore W8635114C160735492 @default.
- W8635114 hasConceptScore W8635114C162324750 @default.
- W8635114 hasConceptScore W8635114C20387591 @default.
- W8635114 hasConceptScore W8635114C204787440 @default.
- W8635114 hasConceptScore W8635114C2426938 @default.
- W8635114 hasConceptScore W8635114C2780062483 @default.
- W8635114 hasConceptScore W8635114C50522688 @default.
- W8635114 hasConceptScore W8635114C512399662 @default.
- W8635114 hasConceptScore W8635114C71924100 @default.
- W8635114 hasConceptScore W8635114C98274493 @default.
- W8635114 hasLocation W86351141 @default.
- W8635114 hasOpenAccess W8635114 @default.
- W8635114 hasPrimaryLocation W86351141 @default.
- W8635114 hasRelatedWork W1003547016 @default.
- W8635114 hasRelatedWork W1630925192 @default.
- W8635114 hasRelatedWork W1963614294 @default.
- W8635114 hasRelatedWork W2060740341 @default.
- W8635114 hasRelatedWork W2082836501 @default.
- W8635114 hasRelatedWork W2180176825 @default.
- W8635114 hasRelatedWork W2220347419 @default.
- W8635114 hasRelatedWork W2277913221 @default.
- W8635114 hasRelatedWork W2324089591 @default.
- W8635114 hasRelatedWork W243769019 @default.
- W8635114 hasRelatedWork W252524009 @default.
- W8635114 hasRelatedWork W2738782976 @default.
- W8635114 hasRelatedWork W283247089 @default.
- W8635114 hasRelatedWork W2992304836 @default.
- W8635114 hasRelatedWork W98159457 @default.
- W8635114 hasRelatedWork W1481642919 @default.
- W8635114 hasRelatedWork W1506424563 @default.
- W8635114 hasRelatedWork W178978301 @default.
- W8635114 hasRelatedWork W1885073903 @default.
- W8635114 hasRelatedWork W2182045542 @default.
- W8635114 isParatext "false" @default.
- W8635114 isRetracted "false" @default.
- W8635114 magId "8635114" @default.
- W8635114 workType "article" @default.